Suzanne Cole, M.D. Titles and Appointments Medical Director, Community Oncology, Simmons Comprehensive Cancer Center Associate Professor School Medical School Department Internal Medicine You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Download Curriculum Vitae Suzanne Cole, M.D., FACP, FASCO is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hematology and Oncology. She serves as the Medical Director and Research Leader of Community Oncology at Harold C. Simmons Comprehensive Cancer Center. Dr. Cole's leadership focuses on expanding access to clinical trials for cancer patients in rural and underserved areas, specifically in Community Oncology, Rural, and Underrepresented Minoruty (CORUM) populations, aiming to ensure diverse patient participation in research. Originally from North Dakota, Dr. Cole earned both a bachelor's degree in biology and a bachelor's degree in modern dance, summa cum laude, from the University of Texas at Dallas. She also obtained a master's degree in humanities at California State University Northridge, graduating with distinction. Dr. Cole earned her medical degree from UT Southwestern, where she also completed internal medicine residency training. She then received advanced fellowship training in hematology and medical oncology at the University of Texas MD Anderson Cancer Center in Houston. Certified by the American Board of Internal Medicine in hematology and oncology, Dr. Cole joined the UT Southwestern faculty in 2018. Before joining UT Southwestern in 2018, Dr. Cole spent eight years providing care in community and rural settings in West Virginia and Oklahoma, which deepened her commitment to improving access to care for underserved populations. Her clinical focus lies in genitourinary (GU) malignancies, and she plays a key role in bringing clinical trial opportunities to UT Southwestern's community clinics in Ricahrdson-Plano, Redbird, and Fort Worth. Dr. Cole is a Fellow of both the American College of Physicians (FACP) and the American Society of Clinical Oncology (FASCO). She has been recognized for her volunteer service and commitment to ASCO, where she held numerous roles, including serving on the Cancer Communications Committee, Diversity and Inclusivity Task Force, Women's Networking Center, and Practice Guidelines Implementation Network. She is also a graduate of ASCO's Leadership Development Program. In addition to her professional achievements, Dr. Cole is an advocate for integrating humanity into medicine, writing narrative medicine stories that highlight the experiences of her patients and their families. She has presented nationally and published widely in peer reviewed journals on cancer and blood disorders. She is also the founder of the Hematology & Oncology Women Physician Group and has served on the board of the Oklahoma Society of Clinical Oncology. Dr. Cole was named by D Magazine as one of Dallas’s Best Doctors in Medical Oncology in 2020-2024 and is one of America's Best Prostate Cancer Oncologists by Newsweek in 2024. Education Medical School UT Southwestern Medical School (2003) Residency UT Southwestern Medical Center (2006), Internal Medicine Fellowship UT MD Anderson Cancer Center (2010), Hematology Oncology Research Interest Conduct of Clinical Trials in Community Oncology Setting Genitourinary Cancer: Bladder Cancer, Kidney Cancer, Prostate Cancer Obtaining prospective Real World Data in patients not eligible or able to participate in clinical trials Publications Featured Publications Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma. Apolo AB, Ballman KV, Sonpavde G, Berg S, Kim WY, Parikh R, Teo MY, Sweis RF, Geynisman DM, Grivas P, Chatta G, Reichert ZR, Kim JW, Bilen MA, McGregor B, Singh P, Tripathi A, Cole S, Simon N, Niglio S, Ley L, Cordes L, Srinivas S, Huang J, Odegaard M, Watt C, Petrylak D, Hoffman-Censits J, Wen Y, Hahn O, Mitchell C, Tan A, Streicher H, Sharon E, Moon H, Woods M, Halabi S, Perez Burbano G, Morris MJ, Rosenberg JE, N Engl J Med 2024 Sep Socioeconomic and Demographic Disparities in Immunotherapy Utilization for Advanced Kidney and Bladder Cancer. Holland L, Bhanvadia R, Ibeziako N, Taylor J, Gerlt D, Chaplin I, Bagrodia A, Desai N, Gaston K, Lotan Y, Margulis V, Zhang T, Cole S, Woldu S, Urol Oncol 2024 Jul Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study. Allaf ME, Kim SE, Master V, McDermott DF, Harshman LC, Cole SM, Drake CG, Signoretti S, Akgul M, Baniak N, Li-Ning E, Palmer MB, Emamekhoo H, Adra N, Kaimakliotis H, Ged Y, Pierorazio PM, Abel EJ, Bilen MA, Ogan K, Moon HH, Ramaswamy KA, Singer EA, Mayer TM, Lohrey J, Margulis V, Gills J, Delacroix SE, Waples MJ, James AC, Wang P, Choueiri T, Michaelson MD, Kapoor A, Heng DY, Shuch B, Leibovich BC, Lara PN, Manola J, Maskens D, Battle D, Uzzo R, Bratslavsky G, Haas NB, Carducci MA, Lancet Oncol 2024 Jun Actionable genomic landscapes from a real-world cohort of urothelial carcinoma patients. Gerald T, Margulis V, Meng X, Bagrodia A, Cole S, Qin Q, Call SG, Mauer E, Lotan Y, Woldu SL, Urol Oncol 2023 Mar 41 3 148.e17-148.e24 Who Should Be Responsible for Relief of Financial Toxicity? Symington BE, Abdel Karim NF, Kenney LB, Cole SM, Crawley MA, Kaur GNMN, Sullivan JE, JCO Oncol Pract 2022 Mar OP2100885 The impact of race and ethnicity on outcomes of patients with myelodysplastic syndromes: a population-based analysis. Goksu SY, Ozer M, Goksu BB, Wang R, Khatib J, Patel PA, Vusirikala M, Cole S, Seyhanli A, Collins RH, Chung S, Zeidan AM, Madanat YF, Leuk Lymphoma 2022 Feb 1-9 Women Oncologists' Perceptions and Factors Associated With Decisions to Pursue Academic vs Nonacademic Careers in Oncology. Merfeld EC, Blitzer GC, Kuczmarska-Haas A, Pitt SC, Chino F, Le T, Allen-Rhoades WA, Cole S, Marshall AL, Carnes M, Jagsi R, Duma N, JAMA Netw Open 2021 Dec 4 12 e2141344 Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma. Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R, Adv Radiat Oncol 2021 Sep-Oct 6 5 100692 Effect of Doxorubicin on Myocardial Bicarbonate Production from Pyruvate Dehydrogenase in Women with Breast Cancer. Park JM, Reed GD, Liticker J, Putnam WC, Chandra A, Yaros K, Afzal A, MacNamara JP, Raza J, Hall RG, Baxter J, Derner K, Pena S, Kallem RR, Subramanyan I, Edpuganti V, Harrison C, Muthukumar A, Lewis C, Reddy S, Unni N, Klemow D, Syed S, Li HC, Cole SM, Froehlich T, Ayers CR, de Lemos JA, Malloy CR, Haley B, Zaha VG, Circ Res 2020 Oct Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer Management. Marcus C, Butler P, Bagrodia A, Cole S, Subramaniam RM, AJR Am J Roentgenol 2020 08 215 2 267-276 Results 1-10 of 16 1 2 Next Last Honors & Awards America's Best Prostate Cancer OncologistsNewsweek (2024) Outstanding Undergraduate Medical Education Faculty Teaching AwardDepartment of Internal Medicine, UT Southwestern Medical Center (2024) Distinguished Alumni AwardUniversity of Texas at Dallas (2022) Best Doctor, Medical OncologyD Magazine (2020-2024) NCI Outstanding Clinical Trial Accrual Silver Physician AwardNational Cancer Institute Commnity Oncology Research Program (2018) Congressional Commendation for Medical Relief to Alexandria, LA during Hurricane HarveyCongressman Ralph Abraham, Louisiana 5th Congressional District, U.S. House of Representatives (2017) J. W. Norwood Distinguished Alumni AwardBurleson High School Alumni Association (2017) Top Doctor, Medical OncologyOklahoma Magazine (2017-2018) ASCO Leadership Development GraduateAmerican Society of Clinical Oncology (2016-2017) Letter of Commendation for Patient Care ServicesCharleston Area Medical Center (2011) Outstanding Clinical Medicine Resident Teaching AwardUT Southwestern Medical Center (2004-2005) Professional Associations/Affiliations American College of Physicians (2006) American College of Physicians (2015) American Society of Clinical Oncology (2007) American Society of Clinical Oncology (2023) American Society of Hematology (2007) ECOG-ACRIN Cancer Research Group (2018) SWOG Cancer Research Group (2017)
